Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Cartilage Degeneration Market In 2029?

The market size for cartilage degeneration has seen substantial increase in the last few years. The market, which is projected to escalate from $12.63 billion in 2024 to $13.4 billion in 2025, has a compound annual growth rate (CAGR) of 6.2%. The impressive growth during the historical period is attributed to factors such as an aging population, joint injuries, a widespread obesity crisis, sports-related injuries, and limited capacity for self-repair.

What Growth Rate Is Forecasted for the Cartilage Degeneration Market by 2029?

In the coming years, the market for cartilage degeneration is predicted to experience robust expansion. It is anticipated to reach $16.62 billion in 2029, with a compound annual growth rate (CAGR) of 5.5%. Factors contributing to this growth during the forecast period include progress in regenerative medicine, biologic injections, tissue engineering techniques, precision medicine, and robotics-assisted surgery. Upcoming trends for the forecast period encompass stem cell treatments, orthopedic 3D printing, gene therapy focused on cartilage restoration, individually tailored rehabilitation schemes, and the utilization of telemedicine for successive care.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13103&type=smp

Which Key Companies Are Shaping the Future of the Cartilage Degeneration Market?

Major companies operating in the cartilage degeneration market report are Johnson & Johnson Services Inc., MEDIPOST Co. Ltd., Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith and Nephew PLC, B Braun Melsungen AG, Osiris Therapeutics Inc., Arthrex Inc., Conmed Corporation, Orthocell Ltd., Bioventus LLC, Aesculap Inc., Vericel Corporation, Anika Therapeutics Inc., Geistlich Pharma AG, MatTek Corporation, Breg Inc., Isto Biologics Inc., OrthoTrophix LLC, CellGenix GmbH, CartiHeal Inc., Cayenne Medical Inc., Collagen Solutions PLC, Regentis Biomaterials Ltd., Histogen Inc., BioTime Inc., CollPlant Holdings Ltd.

Which Factors Are Driving Demand in the Cartilage Degeneration Industry?

The escalating rates of obesity are predicted to fuel the expansion of the cartilage degeneration market in the future. Defined as a health condition in which an individual’s body fat accumulates excessively to the point of detrimental health effects, obesity can precipitate and expedite cartilage degeneration with the intensification of compressive forces on cartilage and inflammatory cytokines. Obesity provokes numerous pathologic transformations in the entire structure of the knee joint such as irregular strain on the joint, malalignment of the joint, and weakening of the muscles. To exemplify, the Government Digital Service, a UK government agency, reported in May 2023 that approximately 63.8% of adults, 18 years old and above, were either overweight or categorised as obese in 2021-2022, a rise from 63.3% in the preceding year. In addition, it was estimated that 25.9% of these adults were obese, marking a 25.2% increase from 2020 to 2021. Consequently, the escalating incidence of obesity is a key driver of the cartilage degeneration market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13103&type=smp

How Is the Cartilage Degeneration Market Segmented by Several Divisions?

The cartilage degeneration market covered in this report is segmented –

1) By Procedure: Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell-Based Cartilage Resurfacing, Autologous Chondrocyte Implantation, Other Procedures

2) By Application: Knee, Hip, Other Applications

3) By End User: Hospitals And Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes

Subsegments:

1) By Joint Replacements: Knee Replacement (Partial, Total), Hip Replacement (Partial, Total), Shoulder Replacement (Total, Reverse), Other Joints (Ankle, Elbow, Wrist)

2) By Chondroplasty: Radiofrequency Ablation Chondroplasty, Mechanical Chondroplasty, Thermal Chondroplasty, Arthroscopic Chondroplasty

3) By Osteochondral Transplants: Autografts (OATS), Allografts (Fresh Osteochondral Allografts), Synthetic Implants

4) By Microfracture: Traditional Microfracture, Augmented Microfracture (with scaffolds or matrix implants)

5) By Meniscus Transplants: Allograft Meniscus Transplantation (Cryopreserved, Fresh Frozen), Synthetic Meniscus Implants

6) By Cell-Based Cartilage Resurfacing: Autologous Cell-Based Therapy, Allogeneic Cell-Based Therapy, Stem Cell-Based Cartilage Repair

7) By Autologous Chondrocyte Implantation (ACI): First-Generation ACI, Second-Generation ACI, Third-Generation ACI (MACI)

8) By Other Procedures: Arthroscopic Debridement, Osteotomy, Cartilage Repair Using Synthetic Scaffolds, Injection-Based Therapies (Hyaluronic Acid, PRP, Stem Cell Injections)

What are the Emerging Market Trends Driving the Growth of the Cartilage Degeneration Industry?

Leading cartilage degeneration market players are introducing unique products like Agili-C to aid in bone restructuring and cartilage renewal. Agili-C is an off-the-shelf, cell-free implant designed to mend cartilage and osteochondral flaws in both traumatic and osteoarthritic joints. For example, CartiHeal Ltd., a medical device company from Israel, announced its first commercial insertion of Agili-C in July 2023. The primary purpose of this implant is to promote the natural regeneration of articular cartilage and subchondral bone, rather than depending on cellular or growth factors. Comprised of natural calcium carbonate or aragonite that originates from coral exoskeletons, the implant instigates the migration of chondrocytes from the adjacent cartilage into the scaffold, creating an extracellular matrix. This certification adds worth to the implant, assuring both patients and healthcare professionals of its safety and effectiveness as a treatment choice.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cartilage-degeneration-global-market-report

Which Regions Are Driving Growth in the Cartilage Degeneration Market?

North America was the largest region in the cartilage degeneration market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cartilage degeneration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13103

This Report Delivers Insight On:

1. How big is the cartilage degeneration market, and how is it changing globally?

2. Who are the major companies in the cartilage degeneration market, and how are they performing?

3. What are the key opportunities and risks in the cartilage degeneration market right now?

4. Which products or customer segments are growing the most in the cartilage degeneration market?

5. What factors are helping or slowing down the growth of the cartilage degeneration market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model